Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
Sponsor: Mayo Clinic
Summary
For most brain tumors, radiation treatment is guided by a Magnetic Resonance Imaging (MRI) scan. In this study, information from a special scan, called a Positron Emission Tomography/ Computed Tomography (PET/CT) scan using an amino acid called Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) will also be used. This type of scan has shown promise in being able to better distinguish tumor from normal brain tissue and may help to more accurately plan radiation treatment. This type of scan can also assist the radiation oncologist in identifying the most aggressive regions of the tumor. The goal of this study is to compare the 18F-DOPA PET/CT scan with the MRI scan for identifying where the disease is that needs to be treated with radiation.
Official title: A Pilot Study Evaluating the Utility of 18F-DOPA PET for Radiotherapy Treatment Planning of Malignant Glioma Patients
Key Details
Gender
All
Age Range
7 Years - Any
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2014-04-08
Completion Date
2031-03
Last Updated
2026-04-06
Healthy Volunteers
No
Conditions
Interventions
Fluorine-18-L-dihydroxyphenylalanine
5 millicuries ± 10%; Intravenous injection; 1 time
Locations (1)
Mayo Clinic
Rochester, Minnesota, United States